Avon Sponsors 3-Day Walk to Raise Funds for Breast Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 8
Volume 7
Issue 8

LOS ANGELES--Avon’s Breast Cancer 3-Day is a new type of fundraising event--the first-ever multiday long distance walk. On October 23, 24, and 25, 1998, nearly 2,000 people in California will walk 50 to 60 miles (15 to 25 miles a day), beginning just south of Santa Barbara and ending just north of Malibu. Each participant has pledged to raise a minimum of $1,700 to support breast cancer awareness and education.

LOS ANGELES--Avon’s Breast Cancer 3-Day is a new type of fundraising event--the first-ever multiday long distance walk. On October 23, 24, and 25, 1998, nearly 2,000 people in California will walk 50 to 60 miles (15 to 25 miles a day), beginning just south of Santa Barbara and ending just north of Malibu. Each participant has pledged to raise a minimum of $1,700 to support breast cancer awareness and education.

The walk is part of a larger, nationwide program called Avon’s Breast Cancer Awareness Crusade. Its mission is to provide women across the country, particularly those who are medically under-served, with access to a full range of breast cancer education and early detection screening services.

Net proceeds from the money raised by the walk will be awarded to nonprofit breast health programs nationwide through The Avon Breast Health Access Fund, administered by the National Alliance of Breast Cancer Organizations (NABCO). Avon has raised $25 million for the fund since 1993, and has made grants to 288 programs.

Because Avon’s Breast Cancer 3-Day is a walk, not a race, each participant will go at his or her own pace. Even so, the walk will be an arduous task for many. To help participants prepare, each has been assigned a walk coach who will provide support and tips throughout the training process. Additionally, walkers can join special training clubs that will organize practice walks before the event.

The walks will be supported by crews who will provide water and refreshment stops, meals, showers, tents, and transportation of gear. For further information about walking, volunteering, or making a pledge, call 888-332-9286.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content